Sapphire Pharma Chairman & CEO Ramu Veerappan to Speak at World Economic Forum 2025

Davos, Switzerland--(Newsfile Corp. - January 19, 2025) - Sapphire Pharma, a global leader in pharmaceutical innovation, proudly announces that its Chairman and CEO, Ramu Veerappan, will be a featured speaker at the prestigious World Economic Forum (WEF) 2025 in Davos, Switzerland. Veerappan will participate in the high-profile panel discussion, "Advancing Malaria Solutions: Enhancing Drug Development, Access, and Global Health Equity."

Addressing a Global Crisis: Sapphire Pharma's Mission to Improve Access to Life-Saving Medicines

Sapphire Pharma, a leader in pharmaceutical innovation, is poised to significantly impact the World Economic Forum (WEF) 2025. Chairman and CEO Ramu Veerappan will represent the company's vision to improve healthcare equity and access during the panel discussion, "Advancing Malaria Solutions: Enhancing Drug Development, Access, and Global Health Equity," scheduled for Monday, January 20, at 2:15 PM Davos time. Malaria remains a devastating public health challenge, with 263 million cases reported globally in 2023, an increase of 11 million cases from the previous year. Nearly 600,000 lives are lost annually to the disease, with 94% of cases concentrated in the WHO African Region. These stark statistics underscore the urgent need for solutions that advance drug development and ensure equitable access to life-saving treatments.

Read more here

‍